Aurinia Pharmaceuticals Inc. (AUPH) is down in the Pre-market; here is why?
Shariq Khan
February 28, 2022
Aurinia Pharmaceuticals Inc. (AUPH) declined in the pre-market after announcing its fourth quarter and fiscal 2021 results. AUPH values at $13.10, losing more than 20%